Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN724595 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN724595, RRID:AB_11185905
- Product name
- anti-CD19 Molecule (CD19) (AA 480-530) antibody
- Antibody type
- Polyclonal
- Description
- Purified by Protein A.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 480-530
- Isotype
- IgG
- Vial size
- 100 μL
- Storage
- Store at -20°C
Submitted references Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.
Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN, Singh PK, Shackelford DB, Lee IK, Shulaev V, Dhar S, Takeda N, Kim JW
American journal of respiratory cell and molecular biology 2018 Feb;58(2):216-231
American journal of respiratory cell and molecular biology 2018 Feb;58(2):216-231
Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y, Ikezumi Y, Saitoh A
Nephrology (Carlton, Vic.) 2017 Jan;22(1):49-57
Nephrology (Carlton, Vic.) 2017 Jan;22(1):49-57
Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Reese SR, Wilson NA, Huang G, Redfield RR 3rd, Zhong W, Djamali A
Transplantation 2015 Sep;99(9):1785-95
Transplantation 2015 Sep;99(9):1785-95
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS